Development and Validation of a Diagnostic Model for AKI Based on the Analysis of Ferroptosis-related Genes
The combination of AEBP2, MDM2, and NR4A1 as diagnostic biomarkers for AKI not only enhances detection capability but also holds promise as a significant tool in clinical practice, providing patients with diagnostic and therapeutic guidance.
Authors
- Yongheng Bai (ORCID: https://orcid.org/0000-0003-3910-4731)
- Xuejia Yang (ORCID: https://orcid.org/0000-0003-3777-5216)
- Zujian Hu (ORCID: https://orcid.org/0000-0001-8662-6765)
- Hengyue Zhu (ORCID: https://orcid.org/0000-0003-1847-4290)
- Jingzong Zhou
- Yangyang Guo (ORCID: https://orcid.org/0000-0002-9744-8113)
- Ziwei Yuan (ORCID: https://orcid.org/0009-0000-8616-2702)
Institutions
- Ningbo University (CN)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Ningbo University Affiliated Hospital (CN)
- Zhejiang Taizhou Hospital (CN)
- Ningbo First Hospital (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2024-11-22
- DOI
- https://doi.org/10.2174/0109298673296300240829075534
- Primary Topic
- Iron Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00